Medtronic P/E 2024

Medtronic P/E

15.16

Medtronic Dividend yield

Ticker

MDT

ISIN

IE00BTN1Y115

WKN

A14M2J

As of Apr 26, 2024, Medtronic's P/E ratio was 15.16, a -48.35% change from the 29.35 P/E ratio recorded in the previous year.

The Medtronic P/E history

Medtronic Aktienanalyse

What does Medtronic do?

Medtronic PLC is a globally leading medical technology company headquartered in Dublin, Ireland. The company was founded in 1949 by Earl Bakken and Palmer Hermundslie and has since developed a comprehensive portfolio of products in the field of medical devices and equipment. Medtronic's business model is focused on meeting the demand for innovative medical technology to improve the quality of life for patients and treat or alleviate diseases and disorders. The company strives to constantly invest in research and development to bring new and improved products to the market. Medtronic offers an extensive range of products that can be used in the fields of cardiology, neuromodulation, spinal surgery, diabetes, hearing aids, surgery, ophthalmology, infection prevention, percutaneous intervention procedures, and more. One of the most well-known product series is the pacemaker, which has been manufactured by Medtronic in a variety of models since 1957. In the field of neuromodulation, Medtronic is a leader in the development of implants that can treat various disorders of the nervous system. This includes deep brain stimulation (DBS) for Parkinson's disease, as well as spinal cord stimulation procedures for chronic pain and neurostimulation procedures for bladder, bowel, and gastrointestinal disorders.. In the field of spinal medicine, Medtronic offers a variety of devices that contribute to the stabilization of the spine and can be implemented through minimally invasive procedures. These include products such as plate systems, cages, spinal stabilizations, chamber drains, medication pumps, and more. In the field of diabetes, Medtronic focuses on the development of insulin pump systems that allow for more precise administration of insulin. The system also includes a sensor that continuously monitors blood sugar levels and can trigger insulin delivery as needed. Medtronic is also known for its efforts in infection prevention, offering products such as antimicrobial catheters, wound care, and hospital hygiene solutions. In addition to its products, the company is also involved in medical education and consulting. As part of these efforts, Medtronic develops training and education programs for physicians and healthcare personnel to enhance techniques and the use of devices and systems. Over the years, Medtronic has expanded its product offering through mergers and acquisitions. Currently, the company employs over 86,000 people in locations across more than 160 countries worldwide. Overall, Medtronic aims to drive innovation in medical technology and enable better healthcare for patients worldwide through its products and services. Medtronic ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Medtronic's P/E Ratio

The Price to Earnings (P/E) Ratio of Medtronic is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Medtronic's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Medtronic is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Medtronic’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Medtronic Stock

What is the price-to-earnings ratio of Medtronic?

The price-earnings ratio of Medtronic is currently 15.16.

How has the price-earnings ratio of Medtronic changed compared to last year?

The price-to-earnings ratio of Medtronic has increased by -48.35% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Medtronic high compared to other companies?

Yes, the price-to-earnings ratio of Medtronic is high compared to other companies.

How does an increase in the price-earnings ratio of Medtronic affect the company?

An increase in the price-earnings ratio of Medtronic would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Medtronic affect the company?

A decrease in the price-earnings ratio of Medtronic would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Medtronic?

Some factors that influence the price-earnings ratio of Medtronic are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Medtronic pay?

Over the past 12 months, Medtronic paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medtronic is expected to pay a dividend of 2.81 USD.

What is the dividend yield of Medtronic?

The current dividend yield of Medtronic is .

When does Medtronic pay dividends?

Medtronic pays a quarterly dividend. This is distributed in the months of July, October, January, April.

How secure is the dividend of Medtronic?

Medtronic paid dividends every year for the past 48 years.

What is the dividend of Medtronic?

For the upcoming 12 months, dividends amounting to 2.81 USD are expected. This corresponds to a dividend yield of 3.55 %.

In which sector is Medtronic located?

Medtronic is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medtronic kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medtronic from 4/12/2024 amounting to 0.69 USD, you needed to have the stock in your portfolio before the ex-date on 3/21/2024.

When did Medtronic pay the last dividend?

The last dividend was paid out on 4/12/2024.

What was the dividend of Medtronic in the year 2023?

In the year 2023, Medtronic distributed 2.67 USD as dividends.

In which currency does Medtronic pay out the dividend?

The dividends of Medtronic are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Medtronic stock can be added to a savings plan with the following providers: Scalable Capital and Consorsbank

Andere Kennzahlen von Medtronic

Our stock analysis for Medtronic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medtronic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.